直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

INCONTESTABLE® Blog

The Return of Fraud? The TTAB Issues Its First Fraud Finding Since In re Bose

November 04, 2014

Authored and Edited by Danny M. Awdeh; Danielle Wright Bulger

For the first time since the Federal Circuit implemented heightened fraud standards in In re Bose, the Board recently sustained an opposition on fraud grounds. Based in significant part on the “manifest lack of credibility of applicant’s testimony,” the Board found that Applicant exceeded the “limits to what may be claimed in good faith.”

In Nationstar Mortgage LLC v. Mujahid Ahmad, the Applicant, a Virginia real-estate agent, filed a use-based application claiming use of the mark NATIONSTAR for a variety of real-estate services, including real-estate, insurance, and mortgage brokerage services. Opposition No. 91177036 (September 30, 2014) [precedential]. However, Applicant’s testimony revealed that at the time the application was filed, Applicant was not licensed to offer, and thus legally could not offer, many of the services identified in the application. Moreover, Applicant testified that he had not used the NATIONSTAR mark on any business documents, lawn signs, or invoices. He also claimed ignorance regarding whether the company he incorporated to offer the applied-for services had actually earned any income or generated any revenue.

The Board was “particularly struck” by Applicant’s evasiveness and failure to respond directly to straightforward questions. For example, when deposed Applicant could not explain when and who created and printed the business cards, flyers, and other documents that Applicant argued supported his alleged use of the NATIONSTAR mark. The Board characterized Applicant’s testimony as “so lacking in conviction and credibility as to be virtually incapable of corroboration” and “not at all credible.”

Distinguishing the facts here from In re Bose, the Board commented that unlike the situation in that case where the alleged “fraud” was based on the applicant’s misunderstanding of the “use in commerce” requirement, this case involved an applicant knowingly making false statements about his use of the mark to induce the PTO into issuing a registration.

“[T]he conclusion that applicant committed fraud on the USPTO seems, to us, to be inescapable.”

Contacts

Danny M. Awdeh
Partner
Washington, DC
+1 202 408 4353
Email

Copyright © 2014 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Lecture

IPIC/McGill Summer IP Course 2026: Understanding Trademarks

July 14, 2026

Montreal

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

At the PTAB Blog

Claim Disclaimer Derails Instituted IPR in Freightcar America

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP